EMC Corporation (NYSE:EMC) today announced that the Company’s Board of Directors has declared a quarterly cash dividend of $0.115 per common share. The dividend will be payable on October 23, 2014 to shareholders of record on October 1, 2014. EMC Corporation (NYSE:EMC)’s stock on 01 August when day-trade ended the stock finally decreased -0.82% to end…
Altair Nanotechnologies, Inc. (NASDAQ:ALTI) reports the company received a non-compliance letter from the Nasdaq Stock Market and has secured a new working capital loan. On May 20, the company received a letter from Nasdaq indicating that the company was not in compliance with the continuous listing rules due to its failure to file its Quarterly…
Merck (NYSE:MRK), which has recently faced a number of patent expirations, on Tuesday reported Q2 sales that slowed for an eighth quarter in a row. But earnings climbed 1% to 85 cents a share for its third straight quarter of gains. Merck & Co. Inc. (NYSE:MRK)’s stock on 01 August traded at beginning with a price…
On 16 July 2014 Aoxing Pharmaceutical Company, Inc. (NYSEMKT:AXN) a specialty pharmaceutical company focusing on research, development, manufacturing, and distribution of narcotic, pain-management, and addiction treatment pharmaceuticals, previously announced that it had received notice from NYSE MKT LLC that, based upon the financial statements contained in Aoxing Pharma’s Annual Report on Form 10-K for the year…
BlackBerry Ltd (NASDAQ:BBRY) said its messaging system BBM, or BlackBerry Messenger, would now be open to those using the Microsoft (MSFT_) Windows phone platform, a move that potentially makes the messaging service more appealing to its enterprise clients, BlackBerry Ltd (NASDAQ:BBRY)’s stock on 01 August traded at beginning with a price of $9.38 and when day-trade ended the stock…
There is no holding back Gilead Sciences’ (GILD – Analyst Report) hepatitis C virus (HCV) drug Sovaldi. The drug continued its exceptional performance in the second quarter of 2014, helping the company to beat the Consensus Estimate in Q2 on both revenues and earnings. The biopharmaceutical company’s second quarter adjusted earnings (including stock based compensation…
